• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchAditxt
    Picture of Aditxt logo

    ADTX — Aditxt News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    • Market Cap
      $2.10m
    • Enterprise Value
      $3.24m
    • Revenue
      $0.00m
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • ADTX Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    ADTX Dividends
    All News

    NASDAQ RESUMED AT 09:00 AM

    Picture of Aditxt logoAditxt
    09/03/2026 13:00
    NASDAQ RESUMED  ADTX.O  AT 09:00 AM
    

    Recent news on Aditxt

    See all news
    • Brief: Ignite Proteomics Announces 10,000-Patient Oncology Registry For Therapy Selection

      08/06/2026 13:41
    • Brief: Aditxt Appoints Jeffrey M. Busch As Interim CEO; Founder And Former CEO Of $1B NYSE Enterprise Which Delivered ~8.5% Dividends To Shareholders

      01/06/2026 13:16
    • NASDAQ TRADE HALT REASON NOT AVAILABLE AT 03:58 AM

      18/05/2026 08:58
    • NASDAQ TRADE HALT HALT NEWS PENDING AT 03:28 AM

      17/05/2026 08:28
    • NASDAQ TRADE HALT HALT NEWS PENDING AT 03:28 AM

      16/05/2026 08:28

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.